Harrow acquires US commercial rights to Byqlovi 0.05% from Formosa Pharma: Nashville, Tennessee Tuesday, June 10, 2025, 14:00 Hrs [IST] Harrow, a leading North American eyecare ph ...

Everest Medicines presents positive results in preliminary analysis of phase 1b/2a trial of novel BTK inhibitor EVER001 at ERA 2025 Congress: Shanghai, China Tuesday, June 10, 202 ...

WuXi Biologics kicks off construction of microbial manufacturing site for commercial production in Chengdu: Chengdu Tuesday, June 10, 2025, 12:00 Hrs [IST] WuXi Biologics, a leadi ...

OneSource's flagship drug-device combination facility maintains its US FDA compliance status: Our Bureau, Bengaluru Tuesday, June 10, 2025, 11:45 Hrs [IST] OneSource Specialty Pha ...

Sanofi accelerates global shipping of Beyfortus to prepare healthcare providers months ahead of 2025-2026 RSV season: Paris Tuesday, June 10, 2025, 11:00 Hrs [IST] Sanofi is shipp ...

Merck reports positive results from the first two phase 3 CORALreef trials of enlicitide decanoate to treat adults with hyperlipidemia: Rahway, New Jersey Tuesday, June 10, 2025, ...

CII Telangana to hold ‘Pillars of Protection’ conference on pharma & chemical industries safety on June 25 at Hyderabad: Our Bureau, Bengaluru Tuesday, June 10, 2025, 09:00 Hr ...

Peethaambaran Kunnathoor, Chennai Tuesday, June 10, 2025, 08:00 Hrs [IST] ...

Experts support Centre’s ban on medical representatives from Central govt hospitals for sales promotion: Shardul Nautiyal, Mumbai Tuesday, June 10, 2025, 08:00 Hrs [IST] Followi ...

CDSCO, DAHD to form JWG to monitor use of antimicrobials in animals: Gireesh Babu, New Delhi Tuesday, June 10, 2025, 08:00 Hrs [IST] In an effort to control the use of antimicrobi ...

Hospitals work on data protection for responsible patient care: Dr Sameer Bhati: Nandita Vijayasimha, Bengaluru Tuesday, June 10, 2025, 08:00 Hrs [IST] Healthcare systems are incr ...

The leading 30 pharmaceutical companies, with revenues above Rs 2,500 crore, have registered robust net profit growth of 31 per cent during the financial year 2024-25 on account of new product ...